Stefan-Lutz Wollin

Title: The Innovations of Stefan-Lutz Wollin

Introduction

Stefan-Lutz Wollin is a notable inventor based in Meersburg, Germany. He has made significant contributions to the field of respiratory medicine through his innovative patents. With a total of 2 patents, Wollin's work focuses on improving treatments for respiratory diseases.

Latest Patents

Wollin's latest patents include a composition comprising a pulmonary surfactant and a TNF-derived peptide. This invention relates to the combination of a pulmonary surfactant and a TNF-derived peptide for the treatment of respiratory diseases. Another significant patent is a composition comprising a pulmonary surfactant and a PDE5 inhibitor for the treatment of lung diseases. This invention addresses the combined administration of a pulmonary surfactant and a PDE5 inhibitor, targeting diseases where pulmonary surfactant malfunction and/or phosphodiesterase 5 (PDE5) activity is detrimental.

Career Highlights

Throughout his career, Wollin has worked with prominent companies in the pharmaceutical industry, including Altana Pharma AG and Nycomed GmbH. His experience in these organizations has contributed to his expertise in developing innovative solutions for respiratory health.

Collaborations

Wollin has collaborated with notable colleagues such as Klaus P. Schaefer and Ingeborg Muehldorfer. These partnerships have further enhanced his research and development efforts in the field.

Conclusion

Stefan-Lutz Wollin's contributions to respiratory medicine through his patents demonstrate his commitment to innovation and improving patient outcomes. His work continues to influence the treatment of respiratory diseases, showcasing the importance of inventive solutions in healthcare.